6 completed, 1 terminated, 1 unknown. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 6, Terminated 1, Unknown 1 |
Follow Seretide: new trials by email Literature Review of Seretide trials Research Report on Seretide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation Seretide, Placebo - Stem Cell Transplant Complications, Respiratory Disease | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 35 | 2021-05-21 | 2025-09-16 |
| Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma. CMAB007, Symbicort, Seretide - Asthma, Allergic | Phase 3 | Completed | Shanghai Biomabs Pharmaceutical Co., Ltd. | 393 | 2018-05-09 | 2021-10-11 |
| Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma Salmeterol Xinafoate and Fluticasone Propinate Powder, Seretide - Asthma | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 300 | 2017-04-01 | 2018-03-12 |
| Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) Aclidinium Bromide / Formoterol Fumarate, Salmeterol / Fluticasone - Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Completed | AstraZeneca | 933 | 2013-09-01 | 2016-03-07 |
| Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients Flutiform, Seretide, Flixotide - Asthma | Phase 3 | Completed | Mundipharma Research Limited | 498 | 2012-03-01 | 2018-10-24 |
| A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma Salmeterol/Fluticasone, Seretide - Asthma | Phase 3 | Completed | Eurofarma Laboratorios S.A. | 334 | 2011-08-01 | 2025-03-31 |
| Comparison of Anti-inflammatory Effects of Seroflo and Seretide in Patients With Asthma Sereflo, Seretide - Asthma | Phase 3 | Completed | Mahidol University | 51 | 2011-02-01 | 2013-09-11 |
| Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139) mometasone furoate combination MDI 200/10 mcg BID, mometasone furoate combination MDI 400/10 mcg BID, Fluticasone/Salmeterol 250/50 mcg BID - Asthma | Phase 3 | Completed | Organon and Co | 404 | 2006-06-01 | 2024-05-20 |
Asthma (6) · Bronchiolitis Obliterans (1) · Pulmonary Disease, Chronic Obstructive (1) · Respiration Disorders (1)
Assistance Publique - Hôpitaux de Paris (1) · AstraZeneca (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Eurofarma Laboratorios S.A. (1) · Mahidol University (1) · Mundipharma Research Limited (1) · Organon and Co (1) · Shanghai Biomabs Pharmaceutical Co., Ltd. (1)
Bulgaria (2) · China (2) · Czechia (2) · France (2) · Hungary (2) · Poland (2) · Austria (1) · Brazil (1) · Canada (1) · Germany (1) · India (1) · Italy (1) · Lithuania (1) · Netherlands (1) · Romania (1)
Esther Garcia, Ph.D. (1) · Kittipong Maneechotesuwan, MD., PhD. (1) · Nanshan Zhong, M.D. (1)
PMID 20874458, PMID 25044280, PMID 27492833, PMID 36472162, PMID 41345745